In the field of regenerative medicine, cell therapy is often used to regenerate organs or tissue that can be widely applied to several diseases. In recent years, the Taiwanese government has listed the biotechnology industry as a key developmental objective and has enacted laws to regulate cell therapy. This has led to substantial change and has necessitated a reliable direction of management in the cell therapy industry. Therefore, this study aims to develop a new method to explore the key success factors in three dimensions of relevant biotechnology company management. It adopts a qualitative method combined with a quantitative analysis method. The study uses Gwo Xi Stem Cell Company, a qualified cell therapy company in Taiwan, as a case study. It adopts a literature analysis method and conducts interviews with cell therapy experts to develop an innovative assessment framework. The analytic hierarchy process is combined with decision-making trial and evaluation laboratory to establish the key success factors in the management of the cell therapy industry. Thus, the study offers strategic recommendations for the development of domestic stem-cell-related industries. The results demonstrate technical characteristics as the most important direction for successful management. Moreover, due to the substantial change in Taiwan's cell therapy industry, technical characteristic-related key success factors, including product development strategy (technical characteristic 1) and technological mastery (technical characteristic 2), are currently considered to be crucial key success factors in decision making.
Keywords: Cell therapy industry; Taiwan; analytic hierarchy process; decision-making trial and evaluation laboratory; key success factor; strategic management.